SCHEMBL21089407

SCHEMBL21089407

N#Cc1ccc(-c2ccc(-c3cc(-c4cccc5c4oc4ccccc45)c4nc(-c5ccccc5O)sc4c3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.43
AR P10275 1/20 0.36
TNKS O95271 1/20 0.35
PIM1 P11309 1/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
PIM3 Q86V86 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
PRKDC P78527 3/20 0.32
PIK3CD O00329 1/20 0.31
PIK3CB P42338 1/20 0.31
ADORA2A P29274 1/20 0.31
KDM4A O75164 1/20 0.31
KDM5B Q9UGL1 1/20 0.31
PTGES2 Q9H7Z7 1/20 0.31
AKR1C3 P42330 1/20 0.31
AKR1C2 P52895 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21089406 0.89 ALOX5 (0.36) ALOX5TNKSPIM1CSNK2A2CSNK2B
SCHEMBL21089493 0.88 ALOX5 (0.45) ALOX5ARTNKSMAPTHPGD
SCHEMBL21089399 0.88 ALOX5 (0.45) ALOX5PIM1CSNK2A2CSNK2BPIM3
SCHEMBL21089461 0.88 ALOX5 (0.50) ALOX5MAPTHPGDSMN1; SMN2PRKDC
SCHEMBL21089496 0.86 ALOX15 (0.38) ARPIM1KDM4AKDM5BLIMK1
SCHEMBL21089269 0.85 ALOX5 (0.46) ALOX5MAPTHPGDSMN1; SMN2PRKDC
SCHEMBL21089316 0.83 ALOX5 (0.47) ALOX5MAPTHPGDSMN1; SMN2PRKDC
SCHEMBL21089211 0.83 ALOX5 (0.47) ALOX5CSNK2A2CSNK2BMAPTHPGD
SCHEMBL21089197 0.82 ALOX5 (0.48) ALOX5MAPTHPGDSMN1; SMN2ADORA2A
SCHEMBL21089455 0.81 ABCB1 (0.39) PIM1HPGDSMN1; SMN2ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11569461-B2 Organic electroluminescence device and organometallic compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2023-01-31 US disclosed
US-20190181358-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANOMETALLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE LAPTO CO., LTD. (KR) 2019-06-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11569461-B2 Organic electroluminescence device and organometallic compound for organic electroluminescence device CHRM1, L1CAM, CHRM4 ALOX5 4229/4885AR 93/4885TNKS 3271/4885
US-20190181358-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANOMETALLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE CHRM1, L1CAM, CHRM4 ALOX5 4229/4885AR 93/4885TNKS 3271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.